BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8437860)

  • 1. Analysis of the neurofibromatosis type 1 (NF1) GAP-related domain by site-directed mutagenesis.
    Gutmann DH; Boguski M; Marchuk D; Wigler M; Collins FS; Ballester R
    Oncogene; 1993 Mar; 8(3):761-9. PubMed ID: 8437860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
    Yan N; Ricca C; Fletcher J; Glover T; Seizinger BR; Manne V
    Cancer Res; 1995 Aug; 55(16):3569-75. PubMed ID: 7627966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of neurofibromatosis type I gene product as an insoluble GTPase-activating protein toward ras p21.
    Hattori S; Maekawa M; Nakamura S
    Oncogene; 1992 Mar; 7(3):481-5. PubMed ID: 1549362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity.
    Andersen LB; Ballester R; Marchuk DA; Chang E; Gutmann DH; Saulino AM; Camonis J; Wigler M; Collins FS
    Mol Cell Biol; 1993 Jan; 13(1):487-95. PubMed ID: 8417346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Ras effector mutant interactions with the NF1-GAP related domain.
    Marshall MS; Hettich LA
    Oncogene; 1993 Feb; 8(2):425-31. PubMed ID: 8426748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ras effector loop mutations that dissociate p120GAP and neurofibromin interactions.
    Stang S; Bottorff D; Stone JC
    Mol Carcinog; 1996 Jan; 15(1):64-9. PubMed ID: 8561868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional assay for heterozygous mutations in the GTPase activating protein related domain of the neurofibromatosis type 1 gene.
    Ishioka C; Ballester R; Engelstein M; Vidal M; Kassel J; The I; Bernards A; Gusella JF; Friend SH
    Oncogene; 1995 Mar; 10(5):841-7. PubMed ID: 7898926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibromatosis type 1 gene mutations in neuroblastoma.
    The I; Murthy AE; Hannigan GE; Jacoby LB; Menon AG; Gusella JF; Bernards A
    Nat Genet; 1993 Jan; 3(1):62-6. PubMed ID: 8490657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural analysis of the GAP-related domain from neurofibromin and its implications.
    Scheffzek K; Ahmadian MR; Wiesmüller L; Kabsch W; Stege P; Schmitz F; Wittinghofer A
    EMBO J; 1998 Aug; 17(15):4313-27. PubMed ID: 9687500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the GTPase-activating domain of human p120GAP and implications for the interaction with Ras.
    Scheffzek K; Lautwein A; Kabsch W; Ahmadian MR; Wittinghofer A
    Nature; 1996 Dec; 384(6609):591-6. PubMed ID: 8955277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperactive Ras as a therapeutic target in neurofibromatosis type 1.
    Weiss B; Bollag G; Shannon K
    Am J Med Genet; 1999 Mar; 89(1):14-22. PubMed ID: 10469432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linear free energy relationships in the intrinsic and GTPase activating protein-stimulated guanosine 5'-triphosphate hydrolysis of p21ras.
    Schweins T; Geyer M; Kalbitzer HR; Wittinghofer A; Warshel A
    Biochemistry; 1996 Nov; 35(45):14225-31. PubMed ID: 8916907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and function of p21 ras proteins.
    Shih TY; Hattori S; Clanton DJ; Ulsh LS; Chen ZQ; Lautenberger JA; Papas TS
    Gene Amplif Anal; 1986; 4():53-72. PubMed ID: 3333361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel, activated RAS mutations alter protein-protein interactions.
    Dalley BK; Cannon JF
    Oncogene; 1996 Sep; 13(6):1209-20. PubMed ID: 8808695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins.
    Ballester R; Marchuk D; Boguski M; Saulino A; Letcher R; Wigler M; Collins F
    Cell; 1990 Nov; 63(4):851-9. PubMed ID: 2121371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A yeast GTPase-activating protein that interacts specifically with a member of the Ypt/Rab family.
    Strom M; Vollmer P; Tan TJ; Gallwitz D
    Nature; 1993 Feb; 361(6414):736-9. PubMed ID: 8441469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the interaction of p21c-Ha-ras-GMP-PNP with full-length neurofibromin and GTPase-activating protein.
    DiBattiste D; Golubic M; Stacey D; Wolfman A
    Oncogene; 1993 Mar; 8(3):637-43. PubMed ID: 8437847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the GAP-related domain impair the ability of neurofibromin to associate with microtubules.
    Xu H; Gutmann DH
    Brain Res; 1997 Jun; 759(1):149-52. PubMed ID: 9219873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation.
    Nishi T; Lee PS; Oka K; Levin VA; Tanase S; Morino Y; Saya H
    Oncogene; 1991 Sep; 6(9):1555-9. PubMed ID: 1923522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [NF1 (neurofibromatosis type 1)].
    Maruta H; Nur-e-Kamal
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1422-6. PubMed ID: 9309135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.